SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AlphaTime Acquisition Corp. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on September 15, 2021 and is headquartered in New York, NY.

AlphaTime Acquisition Corp

ATMC is trending due to a T12 regulatory halt following a massive pre-market surge after approving its merger with HCYC Group. The halt has sparked intense debate and speculation about the future of the stock, particularly given its low float and the potential implications for shareholders and shorts. Community members are discussing potential outcomes from total loss to further gains depending on the nature of the news that emerges.

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Altimmune Inc

ALT is trending as discussions revolve around the potential impact of AI-driven biopsy analysis on its MASH program, particularly after recent FDA news. The community is weighing potential readouts of 48-week data and speculating about buyout scenarios, considering the drug's unique attributes in addressing both MASH and obesity.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending as investors react to news of a joint venture in Romania, meant to challenge China's rare earth dominance. While some see this as a positive step that de-risks the project and improves its NPV, others are concerned about potential delays to the BFS and the company's ability to execute, leading to community discussions around possible short squeezes and government funding.

Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of drug products to extend healthy lifespan. It focuses on developing two novel therapeutic platforms, MyMD-1 and SUPERA-CBD, which aim to treat the causes of disease rather than just addressing the symptoms. MyMD-1 is a clinical-stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cytokines. SUPERA-CBD is a synthetic derivative of cannabidiol being developed to treat conditions such as epilepsy, chronic pain, depression, as well as neuroinflammatory and neurodegenerative diseases. The company was founded in 1989 and is headquartered in New York, NY.

Q/C Technologies Inc.

QCLS is trending amid community discussion around its potential in photonic computing, particularly following endorsements from Martin Shkreli and news around its technology. Some believe QCLS could mirror the recent gains of SMX, while others express skepticism, pointing to the company's history and financial status. The stock's connection to LightSolver's technology and potential applications in crypto and AI are also key talking points.

Top Wealth Group Holding Ltd. operates as a holding company, which provides caviar and caviar-based gourmet products. It focuses on supplying sturgeon caviar to customers under its own brand, Imperial Cristal Caviar. The company was founded by Kim Kwan Kings Wong on February 1, 2023 and is headquartered in Hong Kong.

Top Wealth Group Holding Ltd. - Ordinary Shares - Class A

Top Wealth Group Holding Ltd.

TWG is trending due to significant volatility following a public offering, sparking debates about pump-and-dump schemes and the trustworthiness of Chinese stocks; the community is actively discussing whether to buy the dip or exit positions, with some eyeing similar low-float plays. Despite the volatility, some investors are optimistic about the company's fundamentals, citing increased revenue and improved balance sheets, while others express concerns about dilution and potential for further price drops.

AlphaVest Acquisition Corp. is a blank check company, which engages in effecting a merger, stock exchange, asset acquisition, stock purchase, and reorganization or similar business combination. The company was founded on January 14, 2022 and is headquartered in New York, NY.

AlphaVest Acquisition Corp

AlphaVest Acquisition Corp (ATMV) is trending due to speculation around a potential merger, fueled by the performance of similar stocks. The community is actively discussing price targets and the possibility of a significant short squeeze, given the stock's low float. ATMV's movement is being compared to other high-flying stocks, with some traders suggesting it could reach substantial gains.

Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. The firm's product pipeline includes Cavrotolimod (AST-008) and XCUR-FXN. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in June 2011 and is headquartered in Redwood City, CA.

Exicure Inc

Exicure ($XCUR) is trending due to positive Phase 2 data for its multiple myeloma treatment, Burixafor, presented at the upcoming ASH Annual Meeting. The community is discussing a potential short squeeze, citing a low float and high short interest. Traders are also considering the company's recent purchase agreement and its implications for growth in the biotech sector.

Vor Biopharma, Inc. engages in developing cell therapies for treating cancer. It is a clinical-stage cell therapy company that combines a novel patient engineering approach with therapies to provide a single company solution for patients suffering from hematological malignancies. The company was founded by Aleks Radovic-Moreno and Siddhartha Mukherjee on December 30, 2015 and is headquartered in Boston, MA.

Vor Biopharma Inc

VOR is trending due to JPMorgan initiating coverage with an Overweight rating and a $43 price target, fueling significant pre-market gains. The community is actively discussing potential price targets, technical analysis, and the possibility of a short squeeze given the stock's float and short interest. Some traders are also pointing to milestone events and pipeline developments, further contributing to the stock's upward momentum.

Tronox Holdings Plc engages in the mining and inorganic chemical business. Its products include Titanium Dioxide Mineral Sands. The firm also mines and processes titanium ore, zircon and other minerals, and manufactures titanium dioxide pigments. The company was founded in 2006 and is headquartered in Stamford, CT.

Tronox Holdings plc - Ordinary Shares - Class A

Tronox (TROX) is trending due to conditional financing support for its rare earth strategy, sparking excitement about its potential in the rare earth market. The community is discussing the non-binding nature of the agreement and its potential impact on the company's financial flexibility. Recent insider buying may be contributing to investor confidence.

Astera Labs, Inc. is a global semiconductor company, which engages in the provision of hardware and software solutions for AI and cloud infrastructure applications to solve data, memory, and networking bottlenecks. It operates through the following geographical segments: Taiwan, China, United States, and Other. The company was founded by Jitendra Mohan, Casey Morrison, and Sanjay Gajendra in October 2017 and headquartered in San Jose, CA.

Astera Labs Inc.

Astera Labs Inc

Astera Labs ($ALAB) is experiencing notable volatility, with community members expressing confusion and seeking explanations for recent price swings. Discussions mention potential insider selling and analyst reports, with some highlighting a report suggesting a possible revenue cut from AWS. Despite the uncertainty, many express confidence in the stock's long-term potential, viewing it as an AI infrastructure play.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is Invesco S&P MidCap 400 GARP ETF (GRPM) a Strong ETF Right Now?

Should Invesco S&P MidCap 400 GARP ETF (GRPM) Be on Your Investing Radar?

Shares of Las Vegas-based Boyd Gaming Corp. ($BYD) rose in Friday’s premarket trading following a positive analyst’s action but retail sentiment remained subdued.Jefferies analyst David Katz upgraded&nbsp;<a href="https://stocktwits.com/symbol/BYD">Boyd Gaming stock&nbsp;</a>to ‘Buy’ from ‘Hold,’ and upped the price target to $92 from $73, TheFly reported. The upwardly adjusted price target suggests scope for a 28% upside potential.The analyst sees the company’s capital investment in its regional portfolio, easing comps in Las Vegas and a highly promotional environment that prevailed in 2024 to provide a thrust to the stock this year.Katz predicted 9% year-over-year (YoY) earnings growth due to the company’s commitment to buying back its shares.Additionally, the analyst views that the value of Boyd Gaming’s digital presence through FanDuel is unappreciated. He values the business at $7 per share.Jefferies’ action follows a few positive moves by sell-side analysts recently. Deutsche Bank recently raised the price target for Boyd Gaming from $72 to $79 as part of an estimate update for gaming companies, transitioning the base year from 2025 to 2026.In mid-December, Argus upgraded the stock to ‘Buy’ from ‘Hold,’ with a $90 price target. JPMorgan analyst Joseph Greff lifted the price target for Boyd Gaming stock to $74 from $69 and remained at ‘Neutral.’<figure class="image"><img style="aspect-ratio:632/137;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/byd_sentiment_dd77c279fe.png" alt="byd-sentiment.png" width="632" height="137"><figcaption>BYD sentiment and message volume January 3, 2025, premarket as of 5:25 am ET | Source:&nbsp;Stocktwits</figcaption></figure>On Stocktwits, sentiment toward Boyd Gaming stock deteriorated from ‘neutral’ a month ago to ‘bearish’ (25/100), although message volume improved to ‘high.’Boyd Gaming stock has gained 17% in 2024. After ending Thursday’s session down about 1%, the stock was trading up 3.42% at $74.29 in premarket trading as of 4:52 a.m. ET.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/dating-app-bumble-in-focus-after-analyst-downgrades-stock-citing-near-term-challenges/cW6UGARRlS">Dating App Bumble In Focus After Analyst Downgrades Stock Citing Near-Term Challenges: Retail Stays Cautious</a>

 In this photo illustration, the Boyd Gaming Hospitality company logo seen displayed on a smartphone. 

BYD Gaming Stock Rises In Premarket Following Analyst’s Bullish Recommendation: Retail Sentiment Lags

Jefferies analyst David Katz said the value of Boyd Gaming’s digital presence through FanDuel, which he values at $7 per share, is unappreciated. 

Equity

Jefferies analyst David Katz said the value of Boyd Gaming’s digital presence through FanDuel, which he values at $7 per share, is unappreciated. 


GRPM
Invesco S&P MidCap 400 GARP ETF

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest GRPM News

GRPMInvesco S&P MidCap 400 GARP ETF